基于二维和三维CT特征构建的影像组学列线图预测非小细胞肺癌患者生存
本研究纳入239例训练集和80例、52例两个验证集的非小细胞肺癌患者,从二维和三维CT图像提取975个影像组学特征,用LASSO回归筛选特征并构建影像组学标签,结合临床预测因子建立列线图评估总生存。联合二维和三维特征的影像组学标签预后性能优于单独二维或三维,列线图在验证队列中较临床预测因子单独应用显著提高生存预测能力,校准曲线显示预测生存时间与实际接近。
要点
- 二维和三维影像组学标签均与NSCLC患者生存显著相关,三维标签性能优于二维。
- 联合二维和三维特征的影像组学标签预测性能优于单独二维或三维特征。
- 影像组学标签联合临床预测因子的列线图较临床TNM分期单独应用显著提高生存预测能力。
核心结论
- 联合二维和三维特征的影像组学标签进一步提高了NSCLC患者生存预后预测准确性,最优影像组学标签与临床预测因子联合对个体化生存预后评估表现更好,这些发现可能影响治疗策略并向精准医学迈进。
研究设计与样本
- 研究纳入一个239例训练队列和80例、52例两个验证数据集,从每例患者二维和三维CT图像提取975个影像组学特征,采用LASSO回归筛选特征并生成影像组学标签,进行Cox风险生存分析和Kaplan-Meier分析,整合最优影像组学标签与临床预测因子构建列线图并评估其校准和区分度。
诊断标准与关键数值
- 影像组学标签与NSCLC患者生存时间显著相关。
- 联合二维和三维特征生成的标签预后性能优于单独二维或三维特征生成的标签。
- 影像组学列线图整合最优影像组学标签与临床预测因子,在验证队列中较临床预测因子单独应用对患者生存的预测显著改善。
- 校准曲线显示预测生存时间与实际生存时间非常接近。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to develop a radiomics nomogram by combining the optimized radiomics signatures extracted from 2D and/or 3D CT images and clinical predictors to assess the overall survival of patients with non-small cell lung cancer (NSCLC).
METHODS: One training cohort of 239 and two validation datasets of 80 and 52 NSCLC patients were enrolled in this study. Nine hundred seventy-five radiomics features were extracted from each patient's 2D and 3D CT images. Least absolute shrinkage and selection operator (LASSO) regression was used to select features and generate a radiomics signature. Cox hazard survival analysis and Kaplan-Meier were performed in both cohorts. The radiomics nomogram was developed by integrating the optimized radiomics signature and clinical predictors, its calibration and discrimination were evaluated.
RESULTS: The radiomics signatures were significantly associated with NSCLC patients' survival time. The signature derived from the combined 2D and 3D features showed a better prognostic performance than those from 2D or 3D alone. Our radiomics nomogram integrated the optimal radiomics signature with clinical predictors showed a significant improvement in the prediction of patients' survival compared with clinical predictors alone in the validation cohort. The calibration curve showed predicted survival time was very close to the actual one.
CONCLUSIONS: The radiomics signature from the combined 2D and 3D features further improved the predicted accuracy of survival prognosis for the patients with NSCLC. Combination of the optimal radiomics signature and clinical predictors performed better for individualied survival prognosis estimation in patients with NSCLC. These findings might affect trearment strategies and enable a step forward for precise medicine.
KEY POINTS: • We found both 2D and 3D radiomics signature have favorable prognosis, but 3D signature had a better performance. • The radiomics signature generated from the combined 2D and 3D features had a better predictive performance than those from 2D or 3D features. • Integrating the optimal radiomics signature with clinical predictors significantly improved the predictive power in patients' survival compared with clinical TNM staging alone.
引用
- Yang L, Yang J, Zhou X, et al. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients. Eur Radiol. 2018. PMID: 30523451. doi:10.1007/s00330-018-5770-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。